Skip to content
Home/ Targeted Cancer Therapy (2008)
Targeted Cancer Therapy (2008)

Targeted Cancer Therapy (2008)

No customer reviews yet ISBN 9781603274234

Emerging technologies in target identification, drug discovery, molecular markers, and imaging are rapidly changing the face of cancer. This book provides a foundation of knowledge in targeted cancer therapeutics. The treatment of cancer is increasingly being individualized, based on an understanding of underlying biologic mechanisms. Poised to change the landscape in oncology, this volume provides a state-of-the-art overview. It will be valuable to practicing and academic physicians, fellows, residents and students, as well as basic scientists, interested in the cancer field.

About the author

Product details

Pub dateApr 7, 2008
ISBN-101603274235
ISBN-139781603274234
LanguageEnglish
Last updated 2026-10-10 09:14
$114.64
In stock — ships in 24 hours with free tracking
Delivery by Thursday, October 22, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Oncology - General
See all
Facing Cancer: A Complete Guide for People with Cancer, Their Families, and Caregivers
Stern, Theodore
$20.36
Cancer Pain Management
Fisch, Michael
$251.58
MD Anderson Manual of Psychosocial Oncology
Duffy, James D
$101.14
Gynecologic Oncology: Clinical Practice and Surgical Atlas
Karlan, Beth Y
$320.70
Harrison's Manual of Oncology
Chabner, Bruce a
$95.77
Advances in Cancer Research
Volume 68 of <b>Advances in Cancer Research</b> continues the tradition of publishing up-to-date reviews and "hot" topics in cancer research. This volume begins with a "Foundations in Cancer Research" article by Harald zur Hausen that reviews his years of research on the idea that cancer can be triggered by infection. The structure and function of the cytokine receptor superfamily and its association with leukemias are discussed in depth by James Ihle. Marcia Hall and Gordon Peters review the evidence indicating that genetic abnormalities hinder the function of certain cyclins and their inhibitors. The most widely studied protooncogene, c-<i>myc</i>, is reviewed by Marie Henriksson and Bernhard Lüscher&#x3b; the chapter focuses on the function of c-<i>myc</i> as a transcription factor rather than on the effects of gene translocation and activation on malignancies. Ham Werner and Derek LeRoith present data on the role that insulin-like growth factors play on cell growth and regulation. In the final chapter, Olli-P. Kallioniemi and Tapio Visakorpi investigate the field of prostate cancer and, more importantly, the biological reason and natural history behind the growth of this cancer.
$103.10